Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis
- PMID: 34475129
- DOI: 10.1212/WNL.0000000000012716
Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis
Comment on
-
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.Neurology. 2021 Oct 19;97(16):e1546-e1559. doi: 10.1212/WNL.0000000000012700. Epub 2021 Sep 2. Neurology. 2021. PMID: 34475123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical